testosterone undecanoate: 80mg oral twice a day
Sponsors
The First Affiliated Hospital, College of Medicine, Zhejiang University, The First Affiliated Hospital of Zhejiang University Medical College
Conditions
Myelodysplastic Syndrome
Phase 4
Phase II / III clinical study on the efficacy and safety of recombinant human erythropoietin combined with retinoic acid and testosterone undecanoate in the treatment of anemia in patients with relatively low-risk myelodysplastic syndrome
Active, not recruitingChiCTR2000030594
Start: 2020-04-01Updated: 2020-03-09
Prospective, open-label, multicenter clinical study on the efficacy and safety of recombinant human erythropoietin combined with retinoic acid and testosterone undecanoate in the treatment of anemia in patients with low-risk myelodysplastic syndrome
Active, not recruitingChiCTR2000032845
Start: 2020-05-06Updated: 2020-06-08